Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

BACKGROUND: The novel hormonal drugs have recently entered in the armamentarium of therapies for treatment of metastatic castration-resistant prostate cancer (CRPC). First reports are available for their use in elderly men with CRPC. METHOD: A meta-analysis of randomized controlled trials (RCTs) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Roviello, Giandomenico, Cappelletti, Maria Rosa, Zanotti, Laura, Gobbi, Angela, Senti, Chiara, Bottini, Alberto, Ravelli, Andrea, Bonetta, Alberto, Paganini, Giovanni, Generali, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089083/
https://www.ncbi.nlm.nih.gov/pubmed/27787354
http://dx.doi.org/10.1097/MD.0000000000004636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089083/
https://www.ncbi.nlm.nih.gov/pubmed/27787354
http://dx.doi.org/10.1097/MD.0000000000004636

Ejemplares similares